# Photosensitization Study in Androgenetic Alopecia

> **NCT02791243** · PHASE1 · COMPLETED · sponsor: **Polichem S.A.** · enrollment: 58 (actual)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DRUG:** Finasteride 0.25%
- **DRUG:** Placebo for Finasteride 0.25%
- **DRUG:** Negative Control

## Key facts

- **NCT ID:** NCT02791243
- **Lead sponsor:** Polichem S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-09
- **Primary completion:** 2016-06
- **Final completion:** 2016-06-27
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02791243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02791243, "Photosensitization Study in Androgenetic Alopecia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02791243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*